Targeting the immunological synapse in multiple myeloma
Liu Sumei, Forouzan Bahmani · 2026
Read Targeting the immunological synapse in multiple myeloma by Liu Sumei, Forouzan Bahmani (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13280298.txt.
Description
Sumei Liu and Forouzan Bahmani wrote a review in 2026 on targeting the immunological synapse in multiple myeloma, a cancer of the blood and bone marrow. The immunological synapse is the organized junction that a T cell forms with a cell. It is the fulcrum for T-cell killing of cancer cells.
In multiple myeloma, that junction fails. The review describes how the bone marrow niche, the cancer's environment, disrupts synaptic function and contributes to T-cell dysfunction and immune escape. It sets out strategies to restore the synapse. Bispecific drugs drag T cells into contact with the cancer. Laboratory-built CAR-T cells assemble modified synapses with signaling properties. Approaches include trispecific antibodies, armored and logic-gated CAR-T cells, niche-modifying agents, and nanotechnology. The authors are firm on one point: findings from laboratory mice must not be read as proof of benefit in patients.
Catalog record
| CREATOR | Liu Sumei, Forouzan Bahmani |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |